News That Matters

Health

Dying to deliver: The race to prevent sudden death of new mothers

Dying to deliver: The race to prevent sudden death of new mothers

Health
Four-month-old Muhsin just started laughing – and it’s brought some joy to his father for the first time in a long time. Mustafa Shabazz is proud of the nursery he and his partner Tahmesha Dickey designed for their son, but it’s now reminders of what could have been. "The name on the wall, the crib, everything," Shabazz said. "Muhsin is going to miss out on having a great mother, that’s what hurts so bad about this situation." Dickey, 38, died giving birth to baby Muhsin. Watch the full story on "Nightline" tonight at 12:35 a.m. ET “If I wanted to describe her to someone, I’d describe her as all woman,” Shabazz said. “She was very generous, motivated, dedicated to her family, her work ethic was amazing… she was just a caring lo...
FDA approves first non-opioid withdrawal treatment

FDA approves first non-opioid withdrawal treatment

Health
May 17 (UPI) -- The U.S. Food and Drug Administration said it's approved for the first time a non-opioid drug for treatment of opioid withdrawal. The FDA said the drug Lucemyra, made by US WorldMeds, can be used as part of a long-term treatment for managing opioid use disorder. It treats narcotic withdrawal symptoms like vomiting, muscle aches, diarrhea, anxiety, sleep problems and sweats. "We're dedicated to encouraging innovative approaches to help mitigate the physiological challenges presented when patients discontinue opioids," FDA Commissioner Dr. Scott Gottlieb said in a statement. "We know that the physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and ultimately overcoming addiction." In 2016, two-thirds of drug overdose deaths in...
Clinical trial to offer free 3D-printed prosthetic arms to children

Clinical trial to offer free 3D-printed prosthetic arms to children

Health
May 16 (UPI) -- For the first time, children will be fitted with 3D-printed bionic arms produced as part of a clinical trial. Oregon Health & Science University is collaborating with Limbitless Solutions, a nonprofit based at the University of Central Florida, for the trial, which aims to test the limbs for market approval by the U.S. Food and Drug Administration. The two schools announced Wednesday at a news conference in Orlando that a total of 20 children between age 6 and 17 will be fitted with the devices by the end of this summer at the two schools. The arms will be 3D-printed at UCF for around $ 1,000 each, compared to ones that traditionally cost up to $ 100,000 and need to be replaced as children grow. "This is really like the next level for us," Dr. Albert Manero, CEO of Limbit...